5UR-10637-68349
4 vaccinations
5 coded responses
14 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 452 / OH
- Registered
- 2021-02-21
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-30
Dose 1 — Pfizer-BioNTech
-
2021-02-20
Dose 2 — Pfizer-BioNTech
-
2021-02-21
Registered in v-safe
-
2021-02-21
Survey response — days 1–6 daily, dose 2MedDRA: Respiratory tract congestion — Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessFree text: CongestionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-22
Survey response — days 1–6 daily, dose 2MedDRA: Dizziness, Dyspnoea — Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to workFree text: Dizziness and slight out if breathMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-23
- 2021-02-24
- 2021-02-25
- 2021-02-26
- 2021-03-06
-
2021-05-22
Survey response — 3 months, dose 2MedDRA: Asthma, Fatigue, Hypersensitivity, Pre-existing disease — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Increased need for asthma medication and fatigue but I believe it is related to allergies and other conditions.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-22
Report sent to call center — 3 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
-
2021-06-07
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
-
2021-08-21
Survey response — 6 months, dose 2MedDRA: Nasopharyngitis — Feeling: GoodFree text: I had cold type symptoms last week.MedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-10-06
Dose 3 — Pfizer-BioNTech
-
2023-01-08
Dose 4 — ModernaCo-administered: Pneumonia
-
2023-01-10
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain, Redness · Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2023-01-12
Survey response — days 1–6 daily, dose 4MedDRA: Contusion — Feeling: Good · Site: Pain · Fatigue or tirednessMedDRA releases: 2024-11
- 2023-01-14
- 2023-01-17
- 2023-01-24
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-30 | Pfizer-BioNTech | |
| 2 | 2021-02-20 | Pfizer-BioNTech | |
| 3 | 2021-10-06 | Pfizer-BioNTech | No |
| 4 | 2023-01-08 | Moderna | Pneumonia |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-05-22 | Successful 2021-06-07 |
Not applicable (accidental reporting or does not believe symptoms are related to vaccine) |
Free text
Release 4 — days 1–6 daily, dose 2
Systemic reaction (other): Congestion
Systemic reaction (other): Dizziness and slight out if breath
Release 8 — 3 months, dose 2
Symptoms: Increased need for asthma medication and fatigue but I believe it is related to allergies and other conditions.
Release 9 — 6 months, dose 2
Symptoms: I had cold type symptoms last week.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Asthma | ✓ | ✓ | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Hypersensitivity | ✓ | ✓ | ✓ |
| SD | Nasopharyngitis | ✓ | · | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
| SRO | Contusion | · | · | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
| SRO | Dyspnoea | ✓ | ✓ | ✓ |
| SRO | Respiratory tract congestion | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release